Abstract:Cancer is one of the leading causes of death in the world. Invasive microscopic and endoscopic methods are not suitable for routine screening of gastric cancer. Therefore, the need for biomarkers that can detect quickly, efficiently, and with high sensitivity in the early stages of cancer is strongly felt. Stanniocalcin plays a role in regulating calcium and phosphorus in the body. In addition, it plays a role in neuron cell differentiation, angiogenesis, wound healing, fertility and embryo development, and cancer. This study investigated the level of expression of the Stanniocalcin 2 (STC2) gene in the serum of patients with gastric cancer. This case-control study was conducted on the samples of 60 patients with gastric cancer (cases) and 60 healthy individuals (controls). Peripheral blood samples from gastric cancer patients and volunteers as control groups were collected in tubes containing EDTA anticoagulant and were immediately subjected to serum separation. After centrifugation, serum RNA was extracted, and after cDNA synthesis, STC2 gene serum RNA level was measured by the Taq Man method and Real-time PCR using specific primers and probes. Then, the results of serum evaluations and clinicopathological information of patients and control group were collected along with the information obtained from reviewing patients' files and demographic findings, regulatory tables, and related charts. SPSS22 software was used to analyze descriptive data. According to the study results, the high expression of the STC2 gene was 31 cases in the case group and 13 cases in the control group. However, there was a significant relationship between the high expression of the STC2 gene and gastric cancer (p = 0.0001). However, there was no significant relationship between the gender of patients and high expression of the STC2 gene. However, the age of 35% of the patients was more than 65 years, and there was a significant relationship between the age of the patients and the high expression of the STC2 gene (P = 0.028). Although there was no significant relationship between the anatomical location of the cancer and the subtypes of the cancer and the high expression of the STC2 gene, there was a significant relationship between the degree of cancer differentiation and the high expression of STC2 gene (P<0.05). In general, STC2 can be used as a biomarker to determine the border and margins of the tumor. Analysis of STC2 gene expression during surgery can reduce surgical error in tumor removal and increase the success of surgery for tumor removal.

Detection and Its Significance of Human Stanniocalcin-1 Mrna in the Peripheral Blood from Patients with Colorectal Cancer

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.

Expression and Its Significance of Stanniocalcin-1 Mrna in the Peripheral Blood of Patients with Colorectal Cancer

Detection and Clinical Significance of Histospecific Mrna from Peripheral Blood Cells by Reverse Transcriptase-Polymerase Chain Reaction in Patients with Colorectal Cancer

Human stanniocalcin-1 in venous blood of renal cell carcinoma patients

The expression and clinical signiifcance of Stanniocalcin-1 in breast cancer

Clinical Significance of High Expression of Stanniocalcin-2 in Hepatocellular Carcinoma

The Diagnostic Value of Circulating Stanniocalcin-1 Mrna in Non-Small Cell Lung Cancer

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF CYTOKERATIN 20 mRNA IN CENTRAL VEIN BLOOD OF PATIENTS WITH GASTRIC CANCER BY RT-PCR

Expression of Stathmin in stage II non-small cell lung cancer and its significance

Detection and significance of STC1 in peripheral blood of patients with pulmonary adenocarcinoma

Clinical research on detecting multimarker genera in peripheral blood of patients with colorectal carcinoma and its clinical significance

Detection and Clinical Significance of Histospecific Mrna from Peripheral Blood Cells by Reverse Transcriptase-polymerase Chain Reaction in Patients with Breast Cancer

Evaluating STC2 gene RNA in peripheral blood serum of gastric cancer patients

Detection of CEA Mrna and HNP1-3 in Peripheral Blood of Patients with Colorectal Cancer and Its Clinical Significance

Expression and Clinical Significance of Stathmin in Human Breast Carcinomas

HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor

Evaluation of ST13 gene expression in colorectal cancer patients

Identification of Stanniocalcin 2 As Cancer Marker in Primary Liver Cancer

Expression of Stk15 Mrna in Hepatocellular Carcinoma and Its Prognostic Significance

High expression of HSP70mRNA in human colorectal carcinoma and its clinical implication